Forsite Capital Closes Sixth Fund, focusing on Healthcare and Life Science Startups
American Entrepreneurship
JUNE 13, 2024
Successful track record of investment spurs latest fund supporting biotech innovation Foresite Capital, a multi-stage healthcare and life sciences investment firm continues to do what they do best—investing in companies that leverage biology and big data to transform healthcare. With the recent closing of its Sixth fund of $900 million, the firm stands on a record of 47 IPOs, 28 mergers and acquisitions, and 58 FDA drug approvals since its founding in 2011.
Let's personalize your content